CLINICAL_TRIALS
trial_result
· 2013-05-24
Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine [Phase 2]
Summary
Phase 2 trial evaluating eslicarbazepine acetate as preventive therapy for migraine reports efficacy and safety data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2013-05-24